Chemical

  • The Janssen Family Dynasty: Secular Influence and a 3-Billion-Euro Fortune

    The Janssen family, one of Belgium's most influential dynasties, has positioned itself at the heart of the banking, industrial and pharmaceutical sectors. With assets estimated at over 3 billion euros, their legacy is marked by strategic alliances, notably with the Solvay group and UCB, and by rigorous management of their assets. From Daniel Janssen to Charles-Antoine Janssen, each generation has strengthened the family's grip on the Belgian economy. Discover how this family has combined tradition, innovation and strategy to become one of Belgium's wealthiest.

  • Dr. Paul Janssen: The Visionary Entrepreneur Behind a 300 Million Euro Fortune and a Pharmaceutical Legacy

    Dr. Paul Janssen, founder of Janssen Pharmaceutica, is one of the most influential figures in the Belgian pharmaceutical industry. With a legacy estimated at over 300 million euros, Janssen revolutionized medicine with innovative medicines, while remaining a central figure in the company after its takeover by Johnson & Johnson. In addition to his medical contributions, he left a significant cultural imprint, with a unique collection of pre-Columbian art. Discover how this visionary built a pharmaceutical empire while influencing Belgian art and economics.

  • Putteman family: From Belchim to a 57 million euro fortune in the crop protection industry

    Founded in 1987 by Dirk Putteman, Belchim Crop Protection has become a major player in the distribution of crop protection products in Europe. Despite financial challenges and the loss of its founder, the company continues to prosper thanks to strategic partnerships and a strong international presence. The Putteman family, with an estimated fortune of over 57 million euros, embodies innovation and resilience in the agricultural sector. Discover how their heritage and strategy have shaped a world-renowned company.

  • De Raedt-Verheyden family: Colossal 1.7-billion-euro empire in biotechnology

    Gino De Raedt and Frederica Verheyden have built a financial empire estimated at over 1.7 billion euros, from a simple medical laboratory in 1978 to major players in European biotechnology. Their journey, marked by strategic acquisitions and a spectacular merger with Biogroup, illustrates an exceptional entrepreneurial vision. With record dividends and diversified investments in real estate and private equity, the De Raedt-Verheyden couple have become one of Belgium's largest fortunes, while preparing for the future with their daughter Ann. Their story embodies the perfect blend of scientific innovation and financial genius.

  • 151 Million : Patrick Solvay's Colossal Legacy - From Chemicals to Golf

    Immerse yourself in the world of Patrick Solvay, heir to a chemical and financial empire valued at 151 million euros. From major influence in the global chemical industry to ownership of a prestigious golf course, discover how this great-grandson of Alfred Solvay perpetuates and diversifies the legacy of one of Belgium's most influential families.

  • Maas family: 1-billion-euro dynasty in the global chemicals business

    Immerse yourself in the fascinating story of the Maas family, from their humble beginnings in Zeeland to the creation of a leading chemical distribution company with sales in excess of 1 billion euros. Discover how their vision and strategy fueled global giants like Unilever and Procter & Gamble, marking a lasting legacy in the chemical industry and beyond.

  • Soudal: Swerts family rises to €699M - Belgian Chemical Revolution

    Discover the captivating story of Victor Swerts and his family, who transformed Soudal into a Belgian chemical powerhouse with assets worth 699.2 million euros. From modest beginnings in 1966 to becoming a leader in sealants and silicones in Europe, while navigating global challenges and diversifying their investments, including into entertainment.